Epa Vs Dha — Which Omega-3 Matters More For Your Brain?
Quick Read EPA and DHA are two different omega-3 fatty acids found in fish oil, and they work differently in
Subscribe to the distribution list, to get regular updates on supplement research for health,
🧠 NeuroBright Our evidence-based brain supplement formulated from 1.7M research papers
During World War II, doctors noticed that food rationing led to B vitamin deficiencies, which caused serious brain problems like confusion, memory loss, and mood disturbances. This accidental experiment revealed something important: B vitamins are essential for the brain to work properly. Your brain uses about 20% of your body’s energy despite being only 2% of your weight, and B vitamins help generate that energy and clear toxic waste products that accumulate in the brain.
Eighty years of research has confirmed this connection. Severe B vitamin deficiencies cause documented neurological damage. Mild deficiencies are surprisingly common, especially in people over 40. The strongest evidence focuses on how vitamins B6, B9, and B12 control a toxic protein called homocysteine, which damages nerve cells and blood vessels when it builds up. The most recent large study found that B vitamin supplements produce a small but real improvement in brain function in older adults, rated as high certainty evidence.
The research does not suggest B vitamins will boost your brain by Friday, but rather that maintaining adequate levels over years acts as a preservation strategy. B vitamins are water-soluble so excess is harmless, they are inexpensive, and deficiency is genuinely common. The science suggests taking a full B complex daily makes practical sense for anyone concerned about long-term brain health, though it is one of many factors that matter for healthy ageing.
Verdict: B vitamins support essential brain functions, subclinical deficiency is common especially after 40, and supplementation shows modest but genuine cognitive benefits supported by high-certainty evidence.
It is 1940, and Britain is under siege, not just from bombs, but from an unexpected nutritional experiment that nobody planned. As wartime rationing stripped the diet of millions down to its barest essentials, something curious began to emerge in the medical records. Soldiers and civilians alike were presenting with strange symptoms: confusion, memory lapses, mood disturbances, an almost electric anxiety that doctors struggled to explain through stress alone. Some were showing signs of what we would later recognise as neurological breakdown. The culprit, piece by piece, was traced back to a group of nutrients so ordinary they barely warranted a second glance: the B vitamins.
Nobody set out to run a brain health experiment on an entire population. But that is precisely what rationing did. And what it revealed, confirmed, refined, and built upon across the eight decades of research that followed, is one of the most important stories in nutritional neuroscience. Here is what those decades have taught us.
In the early 1940s, the dominant medical view was that the brain was largely self-sufficient, a sealed organ that drew what it needed from the body and managed the rest. Nutrition was something you worried about for muscles and organs. The idea that what you ate for breakfast could influence how clearly you thought by lunchtime was, to many physicians of the era, borderline eccentric.
Wartime deficiency changed that view rather forcefully.
Thiamine (B1) deficiency produced Wernicke-Korsakoff syndrome, a catastrophic neurological collapse involving severe memory loss and confusion. Niacin (B3) deficiency caused pellagra, which included psychosis as one of its defining features. The pattern was impossible to ignore: deplete these vitamins and the brain, quite visibly, began to malfunction. Restore them, and, in many cases, function returned [5].
What made this medically significant was not just the drama of severe deficiency. It was the quieter realisation that followed: if *extreme* depletion caused obvious neurological breakdown, what was *mild*, subclinical depletion doing? That question has driven nutritional neuroscience ever since.
To understand why B vitamins matter so much to the brain, you need to appreciate what the brain actually demands from the body minute to minute. It is the most metabolically expensive organ you own, consuming roughly 20% of your body’s energy despite accounting for only 2% of your body weight. Running that engine requires a constant, efficient supply of energy, and B vitamins sit at the very heart of that process.
Thiamine (B1), riboflavin (B2), and niacin (B3) function as co-enzymes in energy production, essentially the molecular tools that make the Krebs cycle and electron transport chain work. Without them, nerve cells cannot generate the energy they need to fire, repair, and survive [5]. B1 is involved directly in the Krebs cycle; B2 powers the electron transport chain; B3 plays a key role in both glycolysis and the Krebs cycle [5].
Then there is a second, equally important pathway, one that became the focus of most modern research. Vitamins B6, B9 (folate), and B12 are indispensable co-enzymes in a process called methylation, specifically the conversion of homocysteine into methionine [5]. This matters enormously because homocysteine, when it accumulates, is directly toxic to nerve cells and to the blood vessels that feed them [8]. Elevated homocysteine is associated with brain atrophy, vascular damage, and accelerated cognitive decline [1].
Think of it this way: B6, B9, and B12 are the chemical workforce responsible for clearing a toxic waste product from your brain’s neighbourhood. When that workforce is under-staffed, even slightly, the waste builds up, and over years and decades, the neighbourhood deteriorates.
Beyond energy and homocysteine, the full B vitamin family also contributes to DNA synthesis and repair, the production of neurotransmitters and signalling molecules, and the maintenance of myelin, the protective sheath that keeps nerve signals sharp and fast [12]. A 2016 review in *Nutrients* made the compelling point that virtually all eight B vitamins play closely inter-related roles in brain function, yet the research community has focused almost exclusively on the B6/B9/B12 homocysteine trio, leaving the contributions of thiamine, riboflavin, niacin, biotin, and pantothenic acid comparatively underexplored [12].
The clearest signal in this entire body of research is not subtle. Severe deficiencies in B vitamins produce documented, serious neurological and psychiatric conditions. Thiamine deficiency causes Wernicke-Korsakoff syndrome. Niacin deficiency causes pellagra, which includes psychosis. Deficiencies in B6, B9, and B12 are associated with elevated homocysteine, which in turn links to depression, dementia risk, and cognitive impairment [5].
A 2025 review in *Frontiers in Psychiatry* synthesised the neuropsychiatric literature and concluded that imbalances across the B vitamin group disrupt key biochemical pathways, including energy metabolism and neurotransmitter synthesis, leading to conditions ranging from asthenia and anxiety through to frank cognitive disorders [5]. The literature is unambiguous on this point: B vitamin insufficiency and brain dysfunction are connected, not coincidentally, but mechanistically.
Evidence grade: Strong, this connection is well-established across decades of epidemiological, clinical, and mechanistic research.
Here is the part that should make you pause. We are not talking about the kind of deficiency that shows up visibly on a hospital ward. A 2016 review in *Nutrients* confirmed that a significant proportion of populations in developed countries, including the UK, suffer from deficiencies or insufficiencies in one or more B vitamins, often without obvious symptoms [12]. Older adults are particularly vulnerable, partly because absorption of B12 decreases with age as stomach acid production declines, and partly because dietary patterns often shift in ways that reduce B vitamin intake [14].
A review published in *The Journals of Gerontology* in 2001 noted that even subclinical differences in B vitamin status appeared to have measurable, subtle influences on cognitive performance, particularly in older adults and clinical populations [14]. This is not the dramatic deficiency of wartime ration lines. It is the quiet, slow insufficiency of a population that eats reasonably well but not quite well enough, over decades.
Evidence grade: Strong for the prevalence of subclinical deficiency; Promising for the direct link between subclinical status and cognitive performance.
One of the most important discoveries to emerge from the post-war research era was the identification of homocysteine as a risk factor for cognitive decline and dementia. A paper published in the *American Journal of Clinical Nutrition* in 2000 laid out the case carefully: elevated homocysteine, driven by inadequate B6, B9, and B12 status, may impair brain function through two distinct routes [8]. First, directly, through neurotoxicity. Second, indirectly, through vascular damage: elevated homocysteine is a recognised risk factor for stroke, thrombosis, and cerebrovascular disease, all of which can cause brain ischemia [8].
A 2010 review confirmed that in older adults, cognitive impairment and incident dementia may be related to the high prevalence of inadequate B vitamin status and elevated homocysteine, with plausible mechanisms including both neurotoxicity and the impairment of methylation reactions vital to central nervous system function [15].
The 2012 review in *Current Pharmaceutical Design* put it plainly: the epidemiological literature documenting the association between poor B vitamin status, elevated homocysteine, and increased risk of neurodegenerative and cerebrovascular disease is compelling and extensive [6]. The question that took decades to answer was whether *supplementing* to correct that status would actually reverse the risk.
Evidence grade: Strong for the association between elevated homocysteine and cognitive risk; Promising to Conflicted for whether supplementation reverses that risk in clinical trials.
This is where the story gets nuanced, and it is worth understanding exactly why, because the nuance is genuinely informative rather than merely frustrating.
A 2025 systematic review and meta-analysis in *Nutrition Reviews*, the most comprehensive analysis available, covering 17 randomised controlled trials and 5,275 participants, found that B vitamin supplementation (B6, B9, or B12, for at least 26 weeks) produced a statistically significant, small benefit on global cognitive function in older adults [1]. When the analysis was cleaned up by removing methodologically weaker studies, the effect size settled at Hedges’ g = 0.110 (95% CI: 0.034 to 0.186), with high certainty and negligible heterogeneity between studies [1]. The authors rated this as high-certainty evidence, which is the gold standard in evidence-based medicine, of a very small but real benefit [1].
A separate 2024 systematic review and meta-analysis across 51 articles involving 42,768 participants found a significant overall impact of folate-based B vitamin supplementation on cognitive function (Z = 3.84) [2]. Interestingly, this analysis noted that whether a country has mandatory folic acid food fortification policies may influence the apparent effect size of supplementation, because if people are already getting enough folate through their food, adding more shows smaller effects [2]. This is one of the key reasons trials have produced inconsistent results across decades and countries.
Evidence grade: Strong for a genuine, small cognitive benefit from B vitamin supplementation in older adults; the effect is real but modest, expect support, not transformation.
If you have ever read headlines about B vitamins and brain health, you may have noticed they seem to contradict each other. “B vitamins slow dementia!” followed three years later by “B vitamins show no benefit!” This is not science failing. It is science doing what science does, revealing complexity.
A 2012 review in *Current Pharmaceutical Design* identified several reasons for the apparent inconsistency [6]. Different trials used different doses. They studied different populations, some already cognitively impaired, some not. Some ran for months, others for years. Some participants had elevated homocysteine at baseline; others did not. Some countries fortify food with folic acid; others do not [2]. And crucially, most trials studied only the B6/B9/B12 sub-group, ignoring the potential contribution of the other five B vitamins entirely [12].
A 2013 review in *ISRN Nutrition* made the important point that RCTs consistently showed supplementation *did* successfully raise B vitamin levels and *did* lower homocysteine, yet failed to show clear cognitive benefit in many cases [7]. The authors argued it would be premature to conclude from this that B vitamin therapy has no potential. The more likely explanation is that the therapeutic window matters, that intervention earlier in life, before cognitive decline has established itself, may show larger effects than intervention after the fact [7].
The 2025 meta-analysis supports this interpretation: the benefit of supplementation did not differ between people with intact cognition, mild cognitive impairment, or dementia [1]. This suggests B vitamins support brain function broadly, but they are not a reversal treatment for established disease. They are, in the language of the research, a preservation strategy.
Evidence grade: Conflicted in the older literature, converging on Strong for a small real benefit in the most recent, highest-quality meta-analysis.
Science is honest about its limits here, and so are we.
We do not know the optimal dose. Most trials used standard supplementation doses, but a 2016 review argued that doses *greatly in excess* of current governmental recommendations might be needed for meaningful neuroprotection, particularly for the full eight-B-vitamin complex rather than just three of them [12]. This has not been systematically tested.
We do not know the optimal timing. The evidence strongly suggests that B vitamin support works better as prevention than as treatment [7]. But we do not yet have long-term trials that started supplementation in people in their 40s and followed them for decades to measure dementia outcomes. That research is still being designed.
We do not know who benefits most. The 2013 review noted that individual differences in response to B vitamin therapy are significant and poorly understood [7]. Genetic variations in folate metabolism (such as MTHFR gene variants) may mean some people need more B9 than others to achieve the same homocysteine reduction. This personalised nutrition angle is promising but early-stage.
Animal studies are ahead of human trials on mechanism. A 2024 study in the *Journal of Nutritional Biochemistry* explored how B12 and folate affect mitochondrial dynamics and synaptic plasticity in mice, showing fascinating mechanistic pathways for how these vitamins protect nerve cells at a cellular level [3]. These findings are compelling, but they are mouse studies, not human trials. The cellular mechanisms are plausible and align with what we see in humans, but the direct translation has not been confirmed.
The food fortification confound. As the 2024 meta-analysis highlighted, whether a country mandates folic acid fortification of staple foods significantly affects how supplementation trials look [2]. This makes cross-national comparisons genuinely difficult, and it means results from US trials (where fortification is mandatory) may not map cleanly onto UK populations, where fortification policy has historically been more limited.
Here is what a sensible, well-informed person should take from eighty years of research that began, unexpectedly, on wartime ration lines.
The case for B vitamins and brain health is real. It is not the dramatic “prevents dementia” headline that sells supplements badly. It is something more credible and more useful: B vitamins are essential infrastructure for a functioning brain, deficiency is genuinely common (especially over 40), and supplementation shows a small but high-certainty benefit on cognitive function in the best available evidence [1].
The risk-benefit calculation is straightforward. B vitamins are water-soluble, which means excess is excreted in urine, you cannot meaningfully overdose on them at normal supplement doses [12]. They are inexpensive. The risk of subclinical deficiency is real and well-documented [14]. The downside of supplementing unnecessarily is essentially zero; the downside of not supplementing when mildly deficient is slow, cumulative cognitive wear. A sensible person takes a daily B complex and does not agonise over it.
The full B complex matters, not just three of them. The research has been disproportionately focused on B6, B9, and B12 because of the homocysteine story, which is important. But a 2016 review made a compelling case that all eight B vitamins play closely interconnected roles in brain energy, neurotransmitter synthesis, DNA repair, and neurological integrity [12]. Supplementing the full complex, rather than isolated B12 or folic acid alone, is the more rational approach.
Think of it as long-game preservation, not short-term enhancement. The evidence does not support B vitamins as a cognitive booster you will feel by Friday. What the evidence supports is this: maintaining adequate B vitamin status across midlife and beyond reduces your exposure to homocysteine-driven brain damage, supports the energy metabolism your neurons depend on every day, and preserves the biochemical conditions in which your brain can function at its best [8] [15]. That is not a small thing. Over a decade or two, it could matter enormously.
The wartime experiment was unintentional. The lesson was not. Eight decades of research, from pellagra wards to randomised controlled trials involving thousands of participants, has traced a clear line between B vitamin sufficiency and brain health. The effect size in the best trials is modest. The mechanism is solid. The cost of acting on it is minimal. As a practical matter, supplementing a daily B complex is one of the lowest-effort, lowest-risk, highest-sense decisions available to anyone who is serious about their brain for the long term.
*At Vitacuity, we read the research so you don’t have to. Our team has analysed over 1.77 million research papers to bring you the most relevant, honest findings on brain health and healthy ageing, including the 15 key papers that informed this article.*
[1] Efficacy of B Vitamin Supplementation on Global Cognitive Function in Older Adults: A Systematic Review and Meta-analysis (2025). *Nutrition Reviews*. DOI: 10.1093/nutrit/nuaf155 | https://pubmed.ncbi.nlm.nih.gov/40966571/
[2] A Comparative Study Evaluating the Effectiveness of Folate-Based B Vitamin Intervention on Cognitive Function of Older Adults under Mandatory Folic Acid Fortification Policy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (2024). https://pubmed.ncbi.nlm.nih.gov/39064642/
[3] Vitamin B12 and Folic Acid, Mitochondrial Dynamics and Memory (2024). *Journal of Nutritional Biochemistry*. DOI: 10.1016/j.jnutbio.2023.109536 | https://pubmed.ncbi.nlm.nih.gov/37981108/
[4] Discussing “Associations of Folate/Folic Acid Supplementation Alone and in Combination With Other B Vitamins on Dementia Risk and Brain Structure” (2024). https://pubmed.ncbi.nlm.nih.gov/38949211/
[5] Exploring neuropsychiatric manifestations of vitamin B complex deficiencies (2025). *Frontiers in Psychiatry*. DOI: 10.3389/fpsyt.2025.1569826 | https://pubmed.ncbi.nlm.nih.gov/40904570/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12401900/
[6] B-vitamins for neuroprotection: narrowing the evidence gap (2012). *Current Pharmaceutical Design*. https://pubmed.ncbi.nlm.nih.gov/22419558/
[7] B vitamins and cognitive performance in older adults: review (2013). *ISRN Nutrition*. DOI: 10.5402/2013/650983 | https://pubmed.ncbi.nlm.nih.gov/24959550/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4045270/
[8] B vitamins, homocysteine, and neurocognitive function in the elderly (2000). *American Journal of Clinical Nutrition*. DOI: 10.1093/ajcn/71.2.614s | https://pubmed.ncbi.nlm.nih.gov/10681269/
[9] Vitamin B6, B12, and folic acid supplementation and cognitive function: a systematic review of randomized trials (2007). https://pubmed.ncbi.nlm.nih.gov/17210874/
[12] B Vitamins and the Brain: Mechanisms, Dose and Efficacy, A Review (2016). *Nutrients*. DOI: 10.3390/nu8020068 | https://pubmed.ncbi.nlm.nih.gov/26828517/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772032/
[13] B vitamins and brain dysfunction (2023). https://pubmed.ncbi.nlm.nih.gov/37490672/
[14] B vitamins, cognition, and aging: a review (2001). *The Journals of Gerontology*. DOI: 10.1093/geronb/56.6.p327 | https://pubmed.ncbi.nlm.nih.gov/11682586/
[15] B vitamins and the aging brain (2010). https://pubmed.ncbi.nlm.nih.gov/21091944/
This article is for informational purposes only and does not constitute medical advice. Food supplements should not be used as a substitute for a varied and balanced diet and healthy lifestyle. If you are pregnant, breastfeeding, taking medication or have a medical condition, consult your doctor before taking any supplement. These statements have not been evaluated by the Food and Drug Administration (FDA) or the Medicines and Healthcare products Regulatory Agency (MHRA). This product is not intended to diagnose, treat, cure, or prevent any disease.
Quick Read EPA and DHA are two different omega-3 fatty acids found in fish oil, and they work differently in
Quick Read CoQ10 is a molecule your body naturally produces that helps cells generate energy, particularly in your brain. Your
